The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Emergent BioSolutions (EBS) announced that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro football legend ...

Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...

The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.

Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report) shares fell 7.6% on Friday . The stock traded as low as $0.58 and last traded at $0.67. 500 shares were traded during trading, a decline ...

KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...